CoChat

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H 2 synthases

Open access
Boutaud, Olivier, Aronoff, David M., Richardson, Jacob H., Marnett, Lawrence J., Oates, John A. · 2002 · Proceedings of the National Academy of Sciences

Abstract

Acetaminophen has antipyretic and analgesic properties yet differs from the nonsteroidal antiinflammatory drugs and inhibitors of prostaglandin H synthase (PGHS)-2 by exhibiting little effect on platelets or inflammation. We find parallel selectivity at a cellular level; acetaminophen inhibits PGHS activity with an IC 50 of 4.3 μM in interleukin (IL)-1α-stimulated human umbilical vein endothelial cells, in contrast with an IC 50 of 1,870 μM for the platelet, with 2 μM arachidonic acid as substrate. This difference is not caused by isoform selectivity, because acetaminophen inhibits purified ovine PGHS-1 and murine recombinant PGHS-2 equally. We explored the hypothesis that this difference in cellular responsiveness results from antagonism of the reductant action of acetaminophen on the PGHSs by cellular peroxides. Increasing the peroxide product of the PGHS-cyclooxygenase, prostaglandin G 2 (PGG 2 ), by elevating the concentration of either enzyme or substrate reverses the inhibitory action of acetaminophen, as does the addition of PGG 2 itself. 12-Hydroperoxyeicosatetraenoic acid (0.3 μM), a major product of the platelet, completely reverses the action of acetaminophen on PGHS-1. Inhibition of PGHS activity by acetaminophen in human umbilical vein endothelial cells is abrogated by t -butyl hydroperoxide. Together these findings support the hypothesis that the clinical action of acetaminophen is mediated by inhibition of PGHS activity, and that hydroperoxide concentration contributes to its cellular selectivity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.102588199

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Research works printed but not linked: 10

  1. A H Sutor, E J Bowie, C A Owen Mayo Clin Proc 46, 178–181 (1971).
  2. W Feldberg, K P Gupta J Physiol (London) 222, 126P–129P (1972).
  3. U S Muth-Selbach, I Tegeder, K Brune, G Geisslinger Fever 91, 231–239 (1999).
  4. Y Tone, H Inoue, S Hara, C Yokoyama, T Hatae, H Oida, S Narumiya, R Shigemoto, S Yukawa, T Tanabe Eur J Cell Biol 72, 268–277 (1997).
  5. J A Boyd, T E Eling J Pharmacol Exp Ther 219, 659–664 (1981).
  6. P Moldeus, A Rahimtula, B Andersson, M Berggren Adv Exp Med Biol 136, 1099–1107 (1981).
  7. S D Nelson, D C Dahlin, E J Rauckman, G M Rosen Mol Pharmacol 20, 195–199 (1981).
  8. L J Marnett, P H Siedlik, R C Ochs, W R Pagels, M Das, K V Honn, R H Warnock, B E Tainer, T E Eling Mol Pharmacol 26, 328–335 (1984).
  9. 10.1021/bi990470 · doi:10.1021/bi990470
  10. C Patrono Clin Exp Rheumatol 19, S45–S50 (2001).

Cited by

See all 209

Metadata

Authors
Boutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A.
Affiliations
Vanderbilt University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2002-05-14
Volume
99
Issue
10
Pages
7130-7135
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2027253279
Cited by
209
References
65
Citations by year
2025: 2 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 7 · 2020: 3 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 8 · 2015: 10 · 2014: 12 · 2013: 16 · 2012: 9
FWCI
7.87
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (GM 15431)
  • National Institute of General Medical Sciences (GM 15431, T32-GM 07569, P50GM015431, P01GM015431, T32GM007569)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
paracetamol, prostaglandin H synthase, cyclooxygenase, hydroperoxides, prostaglandin G2, endothelial cells, platelets, PGHS-1, prostaglandin H synthase-2, tert-butyl hydroperoxide, 12-hydroperoxyeicosatetraenoic acid, arachidonic acid, interleukin-1 alpha, nonsteroidal anti-inflammatory drugs
MeSH terms
Acetaminophen, Blood Platelets, Cells, Cultured, Cytochrome P-450 Enzyme System, Dose-Response Relationship, Drug, Endothelium, Vascular, Humans, Hydrogen Peroxide, Interleukin-1, Isoenzymes, Membrane Proteins, Prostaglandin-Endoperoxide Synthases, Prostaglandins G, Substrate Specificity, Umbilical Veins, 6-Ketoprostaglandin F1 alpha, Lipid Peroxidation, Dinoprostone, Arachidonic Acid, Cyclooxygenase Inhibitors, Analgesics, Non-Narcotic, Intramolecular Oxidoreductases, Cyclooxygenase 1, Cytochrome P-450 Enzyme Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H 2 synthases. https://app.cochat.ai/papers/10.1073/pnas.102588199
The paper
Boutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002). Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H 2 synthases. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.102588199

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.